Introducing NMDA antagonists into clinical practice: why head injury trials? - Wikidata - awgldk - TriplyDB

Introducing NMDA antagonists into clinical practice: why head injury trials?

Introducing NMDA antagonists into clinical practice: why head injury trials?

http://www.wikidata.org/entity/Q35606205

about

N-methyl-D-aspartate antagonists for stroke and head trauma.CGS 19755 (Selfotel): A Novel Neuroprotective Agent Against CNS Injury.The role of clinical pharmacology in the development and assessment of drugs for cerebrovascular disease and stroke.

P2860

Q34430163-AAFEE908-EB78-4D2B-A62B-25426A0ADAA9 Q38114426-5478E642-C365-467C-ACE9-E9DD8078A05A Q40902920-476F12B3-B558-42CF-9A04-47B897B51BD6

P2860

Introducing NMDA antagonists into clinical practice: why head injury trials?

http://www.wikidata.org/entity/Q35606205

description

1992 nî lūn-bûn

@nan

1992年の論文

@ja

1992年論文

@yue

1992年論文

@zh-hant

1992年論文

@zh-hk

1992年論文

@zh-mo

1992年論文

@zh-tw

1992年论文

@wuu

1992年论文

@zh

1992年论文

@zh-cn

name

Introducing NMDA antagonists into clinical practice: why head injury trials?

@ast

Introducing NMDA antagonists into clinical practice: why head injury trials?

@en

type

label

Introducing NMDA antagonists into clinical practice: why head injury trials?

@ast

Introducing NMDA antagonists into clinical practice: why head injury trials?

@en

prefLabel

Introducing NMDA antagonists into clinical practice: why head injury trials?

@ast

Introducing NMDA antagonists into clinical practice: why head injury trials?

@en

P1433

Q35606205-C008DEAC-ECBE-4AAA-B5C3-37524D2A6E79

P1476

Q35606205-7533930D-F31A-409A-AB2F-75F37CA4A077

P2093

Q35606205-26BB07B2-FB04-420E-9444-ABAAE578F24D

P2860

Q35606205-02718946-2B52-42A8-AEBF-9F0EB16E274F

Q35606205-1372F4EB-6F30-4020-8A7F-1580CD69569A

Q35606205-177244A8-F467-47E7-8A29-6036FCAC8EC4

Q35606205-18AFE7BC-9E14-44B7-B726-390EB05E0961

Q35606205-288A44FD-8381-4EA7-95EC-A8A96E595AB6

Q35606205-44688F67-F65E-4E20-BD6E-09C5450951FD

Q35606205-4B338444-1960-4A8B-9FF1-A5316D770213

Q35606205-69435A33-747C-44C9-90B7-79F462933E41

Q35606205-8BA7261F-022B-41F2-8C42-368EF0372FFB

Q35606205-8C04C15B-3C2B-4A59-9A8D-11290BBB4909

P304

Q35606205-18E2394D-6F30-4CF8-ADCC-38C52F8EA098

P31

Q35606205-7DE2FD0D-D2CB-4246-A543-444D31234BE1

P356

Q35606205-FDB05986-CCA7-48BE-B2D4-9AD322ABE692

P407

Q35606205-AF4C9F5D-AD05-4021-8CBB-E549B935A3FA

P433

Q35606205-A4A46D63-47E5-4057-B009-0920C2B5CFFC

P478

Q35606205-C4D0C0E7-EB8C-4EDD-A453-A6E9FE0E6279

P577

Q35606205-07E1DF95-CE6F-4F94-8E22-97AF8B5C805C

P5875

Q35606205-A3BB7053-B42B-4460-8744-5EFC39341404

P698

Q35606205-9FAB14F5-1635-4267-8B67-177C564D9962

P932

Q35606205-15ADCA94-6E9D-48C8-9CC7-972B9EC15FD7

P356

J.1365-2125.1992.TB05648.X

P1433

British Journal of Clinical Pharmacology

P1476

Introducing NMDA antagonists into clinical practice: why head injury trials?

@en

P2093

Bullock R

http://www.w3.org/2001/XMLSchema#string

P2860

Ischaemic brain damage is still common in fatal non-missile head injury.

Neurotransmitter-mediated mechanisms of traumatic brain injury: acetylcholine and excitatory amino acids.

Massive increases in extracellular potassium and the indiscriminate release of glutamate following concussive brain injury.

Protection against ischaemic neuronal damage by drugs acting on excitatory neurotransmission.

Glutamate and the pathophysiology of hypoxic--ischemic brain damage.

Axonal damage in severe traumatic brain injury: an experimental study in cat.

Glial swelling following human cerebral contusion: an ultrastructural study.

Administration of excitatory amino acid antagonists via microdialysis attenuates the increase in glucose utilization seen following concussive brain injury.

Increased vulnerability of the mildly traumatized rat brain to cerebral ischemia: the use of controlled secondary ischemia as a research tool to identify common or different mechanisms contributing to mechanical and ischemic brain injury.

Ischaemic brain damage in fatal non-missile head injuries.

P304

396-401

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1365-2125.1992.TB05648.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

34

http://www.w3.org/2001/XMLSchema#string

P577

1992-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

21688852

http://www.w3.org/2001/XMLSchema#string

P698

1467133

http://www.w3.org/2001/XMLSchema#string

P932

1381467

http://www.w3.org/2001/XMLSchema#string